1. Review the historical literature of adjuvant chemotherapy in resected NSCLC

2. Discuss the current and future roles of targeted therapy in the adjuvant setting

3. Address the future directions of peri-operative therapy in NSCLC

Session date: 
Thursday, November 10, 2016 - 8:00am to 9:00am
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael Jelinek, MD